SciELO - Scientific Electronic Library Online

 
vol.37 issue 1Intracranial Haemangiopericytoma: Case report and literature reviewPost-traumatic cerebrospinal fluid fistula: proposal of diagnostic and therapeutic algorithm author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • Have no similar articlesSimilars in SciELO

Share


Archivos de Medicina Interna

Print version ISSN 0250-3816On-line version ISSN 1688-423X

Abstract

MEDICI, Conrado et al. N-methyl-D-aspartate anti-receptor encephalitis: first two cases confirmed in pediatrics. Arch. Med Int [online]. 2015, vol.37, n. 1, pp.43-46. ISSN 0250-3816.

Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis is an immunomediated encephalopathy that presents with psiquiatric psymptoms, speech dysfunction, memory problems, seizures, abnormal movements, autonomic dysfunction, hipoventylation and decreased consciousness. The objective of this study is to show the first two pediatric cases of Anti-NMDA receptor encephalitis confirmed in Uruguay. Clinical cases: Two boys, 6 and 14 years old, with Anti-NMDA receptor encephalitis. The first one had a subacute presentation with obsessive-compulsive symptoms and gate disorder while the second started with headaches. Both added mutism, urinary incontinence, behavioral and autonomic dysfunction and movement disorder. Magnetic resonance image and cerebrospinal fluid was normal. Electroencephalogram showed diffuse slow background activity. Serum and cerebrospinal fluid Anti-NMDA antibodies were positive. Both were treated with methylprednisolone and immunoglobulins, one of them also received Rituximab. We want to emphasize the importance of early diagnosis of this immunomediated encephalopathy in order to start treatment as soon as possible.

Keywords : Anti-N-Methyl-D-Aspartate receptor encephalitis; Dystonia; Chorea; Mutism.

        · abstract in Spanish     · text in Spanish

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License